| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
9e-13 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-06 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |